These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22576872)

  • 1. An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.
    Brinkmalm G; Portelius E; Öhrfelt A; Mattsson N; Persson R; Gustavsson MK; Vite CH; Gobom J; Månsson JE; Nilsson J; Halim A; Larson G; Rüetschi U; Zetterberg H; Blennow K; Brinkmalm A
    J Mass Spectrom; 2012 May; 47(5):591-603. PubMed ID: 22576872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran A; Andreasson U; Zetterberg H; Westman-Brinkmalm A; Blennow K; Ohrfelt A
    Exp Neurol; 2010 Jun; 223(2):351-8. PubMed ID: 19559702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
    Augutis K; Axelsson M; Portelius E; Brinkmalm G; Andreasson U; Gustavsson MK; Malmeström C; Lycke J; Blennow K; Zetterberg H; Mattsson N
    Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid.
    Halim A; Brinkmalm G; Rüetschi U; Westman-Brinkmalm A; Portelius E; Zetterberg H; Blennow K; Larson G; Nilsson J
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11848-53. PubMed ID: 21712440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of quantitative LC-MS surrogate peptide methodology in the analysis of the amyloid beta peptide (Abeta) biosynthetic intermediate protein APP-betaCTF.
    Cantone JL; Xu-Lin A; Toyn JH; Drexler DM
    J Neurosci Methods; 2009 Jun; 180(2):255-60. PubMed ID: 19464516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.
    Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Touchon J; Perret-Liaudet A; Lehmann S
    Brain Res; 2010 Oct; 1357():175-83. PubMed ID: 20713025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.
    Lame ME; Chambers EE; Blatnik M
    Anal Biochem; 2011 Dec; 419(2):133-9. PubMed ID: 21888888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of peptide adsorption-controlled liquid chromatography-tandem mass spectrometric (PAC-LC-MS/MS) method for simple and simultaneous quantitation of amyloid β 1-38, 1-40, 1-42 and 1-43 peptides in dog cerebrospinal fluid.
    Goda R; Kobayashi N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():137-45. PubMed ID: 22503736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mass spectrometric approach for characterization of amyloid-β aggregates and identification of their post-translational modifications.
    Tay WM; Bryant JG; Martin PK; Nix AJ; Cusack BM; Rosenberry TL
    Biochemistry; 2012 May; 51(18):3759-66. PubMed ID: 22506642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominance of amyloid precursor protein sequence over host cell secretases in determining beta-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry.
    Du P; Wood KM; Rosner MH; Cunningham D; Tate B; Geoghegan KF
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1144-52. PubMed ID: 17202404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of O-glycosylation structures of the beta-amyloid precursor protein by liquid chromatography-mass spectrometry using electron transfer dissociation and collision induced dissociation.
    Perdivara I; Petrovich R; Allinquant B; Deterding LJ; Tomer KB; Przybylski M
    J Proteome Res; 2009 Feb; 8(2):631-42. PubMed ID: 19093876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
    Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
    Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
    Wu SL; Kim J; Hancock WS; Karger B
    J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
    Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
    J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
    Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
    J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
    Farzan M; Schnitzler CE; Vasilieva N; Leung D; Choe H
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9712-7. PubMed ID: 10931940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model.
    Borghys H; Jacobs T; Van Broeck B; Dillen L; Dhuyvetter D; Gijsen H; Mercken M
    J Alzheimers Dis; 2014; 38(1):39-48. PubMed ID: 23948925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases.
    Böhme L; Hoffmann T; Manhart S; Wolf R; Demuth HU
    Biol Chem; 2008 Aug; 389(8):1055-66. PubMed ID: 18979630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.